Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|June 26, 1999
The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinaseR Schwenzer, K Siemienski, S Liptay, et al.
Science (New York, N.Y.)|June 11, 1998
Distribution of rock, metals, and ices in CallistoJ D Anderson, G Schubert, R A Jacobson, et al.
Science (New York, N.Y.)|September 25, 1998
Europa's differentiated internal structure: inferences from four Galileo encountersJ D Anderson, G Schubert, R A Jacobson, et al.
Frontiers in Veterinary Science|March 11, 2025
Equine neutrophils selectively release neutrophil extracellular traps in response to chemical and bacterial agonistsBreanna J Sheahan, Alicia G Schubert, William Schubert, et al.
Frontiers in Veterinary Science|July 20, 2018
Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory MediatorsJessica M Gilbertie, Julie M Long, Alicia G Schubert, et al.
The Journal of Biological Chemistry|May 24, 2000
Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD)H Wajant, E Haas, R Schwenzer, et al.
Clinical Biochemistry|May 7, 2008
Reference intervals for TSH and thyroid hormones are mainly affected by age, body mass index and number of blood leucocytes, but hardly by gender and thyroid autoantibodies during the first decades of lifeJ Kratzsch, G Schubert, F Pulzer, et al.
Current Biology : CB|March 21, 1998
Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene inductionH Wajant, F J Johannes, E Haas, et al.
Journal of Medicinal Chemistry|January 17, 1997
Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocaseH Hemmerle, H J Burger, P Below, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rateJ Engel, R Eckel, G Schubert-Fritschle, et al.
Pageof 15